MDR1 not CYP3A4 gene expression is the predominant mechanism of innate drug resistance in pediatric soft tissue sarcoma patients-Reference-Cited by-同舟云学术

MDR1 not CYP3A4 gene expression is the predominant mechanism of innate drug resistance in pediatric soft tissue sarcoma patients

Published:2018-05-29 Issue:2 Volume:22 Page:317-324
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Molina-Ortiz Dora¹,Torres-Zárate Carmen¹,Cárdenas-Cardós Rocío²,Palacios-Acosta José Martin³,Hernández-Arrazola Daniel³,Shalkow-Klincovstein Jaime³,Díaz-Díaz Erick¹,Vences-Mejía Araceli¹

Affiliation:

1. Laboratory of Genetic Toxicology, National Institute of Pediatrics, Mexico City, Mexico

2. Department of Pediatric Oncology, National Institute of Pediatrics, Mexico City, Mexico

3. Oncological Surgery Service, National Institute of Pediatrics, Mexico City, Mexico

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference34 articles.

1. Soft tissue sarcomas of childhood;Meyer;Cancer Treat Rev,2004

2. Histology-driven chemotherapy of soft-tissue sarcoma;Eriksson;Ann Oncol,2010

3. The use of chemotherapy in soft-tissue sarcomas;Spira;Oncologist,2002

4. Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy;Blay;Eur J Cancer,2003

5. Drug resistance in cancer: an overview;Housman;Cancers (Basel),2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells;Pharmaceutics;2022-10-13

2. Expression of Cytochrome P450 Enzymes in Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Possible Role in Carcinogenesis and Treatment Response;International Journal of Toxicology;2022-04-19

3. Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity;Cancer Treatment and Research Communications;2022

4. Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway;FEBS Open Bio;2021-07-16

5. Academic paediatric surgery and work-life balance: Insights from Mexico;Seminars in Pediatric Surgery;2021-02